Greater Boston
Biomaterials scientist with experience in product development, business development, and go-to-market strategy. Head of R&D at Ortholevo, a Boston-based pharmaceutical startup, developing treatments for fibrotic diseases targeting joints, muscles, lungs, and connective tissues || www.ortholevo.com || Co-founder of Articulate Biosciences, a preclinical stage medical device startup developing ABX Viscoelastics: More effective injectable gels for treating arthritis and other soft tissue diseases || www.articulatebio.com || Experience: **Polymer chemistry, biomaterials synthesis, physicochemical characterization; polymeric hydrogel musculoskeletal devices and pharmaceutical formulations **Cartilage friction, compression, and wear testing; rheometry, viscometry **Animal protocols, handling, injection, imaging, ex vivo tissue prep and analysis **Six Sigma & Lean operations: Continuous improvement, root cause analysis, contingency planning / failure mode and effects analysis, Quality Management Systems, communication / teamwork / effective policy deployment **Medical device translation: Idea validation, intellectual property, market research, financial research, competitive intelligence, due diligence, cGMP manufacturing, preclinical studies, regulatory processes, grant proposal development and post-award management (NIH, NSF, DOD) **New venture accelerators: Coulter Foundation translation seminars 2015, Boston University Startup Accelerator 2016, Brandeis University Lean LaunchPad Program 2016, NSF I-Corps Site Program 2017
Developing treatments for fibrotic diseases targeting joints, muscles, and connective tissues. Sustained-release relaxin: A single joint injection with lasting efficacy to treat joint stiffness and restore full motion
Commercializing injectable medical device gel for treating osteoarthritis, developed during doctoral studies at Boston University. Leading product and business development; seeking strategic partnerships.
Advising, consulting, & contracting
**Applied and evaluated innovative polymer synthetic techniques in treatment of damaged and deteriorated cartilage **Engaged in cross-disciplinary research: orthopedics, engineering, and animal work (in vivo rat; ex vivo rabbit, cow)